The role of adhesion molecules in multiple sclerosis: Biology, pathogenesis and therapeutic implications

Molecular Medicine Today

Volumn 3, Issue 7, 1997, Pages 310-321

  Archeles, Juan J ^a,b   Hartung, Hans Peter ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE;

ANTIGEN PRESENTATION; CELL INFILTRATION; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; MULTIPLE SCLEROSIS; PATHOGENESIS; REVIEW;

ANIMALS; CELL ADHESION MOLECULES; CENTRAL NERVOUS SYSTEM; CLINICAL TRIALS; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; MULTIPLE SCLEROSIS;

EID: 0031416214     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(97)01066-6     Document Type: Review

References (54)

1. Raine, C.S., McFarland, H.F. and Tourtelotte, W.W., eds (1997) Multiple Sclerosis: Clinical and Pathogenetic Basis, Chapman & Hall
2. Cook, S.D., ed. (1996) Handbook of Multiple Sclerosis, Marcel Dekker
3. Raine, C.S. (1997) The lesion in multiple sclerosis and chronic relapsing experimental allergic encephalomyelitis: a structural comparison, in Multiple Sclerosis: Clinical and Pathogenetic Basis (Raine, C.S., McFarland, H.F. and Tourtellotte, W.W., eds), pp. 243-286, Chapman & Hall
4. Raine, C.S. (1991) Multiple sclerosis: a pivotal role for the T cells in lesion development, Neuropath. Appl. Neurobiol. 17, 265-274
5. Swanborg, R.H. (1995) Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease. Clin. Immunol. Immunopathol. 77, 4-13
6. Massacesi, L. et al. (1995) Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis, Ann. Neurol. 37, 519-530
7. Steinman, L. (1996) A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry, Proc. Natl. Acad. Sci. U. S. A. 93, 2253-2256
8. Butcher, E. and Picker. L.J. (1996) Lymphocyte homing and homeostasis, Science 272, 60-66
9. Oppenheimer-Marks, N. and Lipsky, P.E. (1996) Adhesion molecules as targets for the treatment of autoimmune diseases, Clin. Immunol. Immunopathol. 79, 203-210
10. Reiser, H. and Stadecker, M.J. (1996) Co-stimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases, New Engl. J. Med. 335, 1369-1377
11. Hartung, H.P. et al. (1995) Circulating adhesion molecules and inflammatory mediators in demyelination, Neurology 45 (Suppl. 6), S22-S32
12. Vanderlugt, C.T. and Miller, S.D. (1996) Epitope spreading, Curr. Opin. Immunol. 8, 831-836
13. Prineas, J.W. et al. (1993) Multiple sclerosis: remyelination of nascent lesions, Ann. Neurol. 33, 137-151
14. Dopp, J.M., Brenemann, S.M. and Olschowka, J.A. (1994) Expression of ICAM-1, VCAM-1, L-selectin, and leukosialin in the mouse central nervous system during the induction and remission stages of experimental allergic encephalomyelitis, J. Neuroimmunol. 54, 129-144
15. Tsunoda, I. and Fujinami, R.S. (1996) Two models for multiple sclerosis: experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus, J. Neuropathol. Exp. Neurol. 55, 673-686
16. Archelos, J.J. et al. (1993) Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1, Am. Neurol. 34, 145-154
17. 1 integrin, Nature 356, 63-66
18. Cannella, B., Cross, A.H. and Raine, C.S. (1993) Anti-adhesion molecule therapy in experimental autoimmune encephalomyelitis, J. Neuroimmunol. 46, 43-56
19. Hogg, N. and Berlin, C. (1995) Structure and function of adhesion receptors in leukocyte trafficking, Immunol. Today 16, 327-330
20. Newman, P.J. (1997) The biology of PECAM-1, J. Clin. Invest. 99, 3-8
21. Raine, C.S. (1994) Multiple sclerosis: immune system molecule expression in the central nervous system, J. Neuropathol. Exp. Neurol. 53, 328-337
22. Cannella, B. and Raine, C.S. (1995) The adhesion molecule and cytokine profile of multiple sclerosis lesions, Ann. Neurol. 37, 424-435
23. 2 integrin LFA-1 in multiple sclerosis, J. Neuropathol. Exp. Neurol. 55, 1060-1072
24. Windhagen, A. et al. (1995) Expression of co-stimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis, J. Exp. Med. 182, 1985-1996
25. Svenningsson, A. et al. (1993) Adhesion molecule expression on cerebrospinal fluid T lymphocytes: evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls, Ann. Neurol. 34, 155-161
26. Hartung, H.P. et al. (1995) Circulating adhesion molecules and TNF receptor (60 kDa) in multiple sclerosis: correlation with MRI and comparison with viral encephalitis, Ann. Neurol. 38, 186-193
27. Waldmann, H. and Cobbold, S. (1993) The use of monoclonal antibodies to achieve immunological tolerance, Immunol. Today 14, 247-251
28. Cross, A.H. et al. (1995) Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation, J. Clin. Invest. 95, 2783-2789
29. Chamow, S.M. and Ashkenazi, A. (1996) Immunoadhesins: principles and applications, Trends Biotechnol. 14, 52-60
30. Davis, L.S., Kavanaugh, A.F., Nichols, L.A. and Lipsky, P.E. (1995) Induction of persistent T cell hyporesponsiveness in vivo by monoclonal antibody to ICAM-1 in patients with rheumatoid arthritis, J. Immunol 154, 3525-3537
31. Lockwood, C.M. et al. (1993) Long term remission of intractable systemic vasculitis with monoclonal antibody therapy, Lancet 341, 1620-1623
32. Panitch, H.S. (1996) Investigational drug therapies for treatment of multiple sclerosis, Multiple Sclerosis 2, 66-77
33. Hafler, D.A. and Weiner, H.L. (1988) Immunosuppression with monoclonal antibodies in multiple sclerosis, Neurology 38 (Suppl. 2), 42-47
34. Weinshenker, B.G. et al. (1991) An open trial of OKT3 in patients with multiple sclerosis, Neurology 41, 1047-1052
35. Racadot, E. et al. (1993) Treatment of multiple sclerosis with anti-CD4 monoclonal antibody, J. Autoimmun. 6, 771-786
36. Hafler, D.A. et al. (1986) Immunologic responses of progressive multiple sclerosis patients treated with an anti-T-cell monoclonal antibody, anti-TI2, Neurology 36, 777-784
37. Moreau, T. et al. (1996) Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis, Brain 119, 225-237
38. Lindsey, J.W. et al. (1994) Phase 1 clinical trial of chimeric monoclonal anti-CD4 antibody in multiple sclerosis, Neurology 44, 413-419
39. Merrill, J.E. and Benveniste, E.N. (1996) Cytokines in inflammatory brain lesions: helpful and harmful, Trends Neurosci. 19, 331-338
40. 2 decreases migration of lymphocytes in vitro and homing of cells into the central nervous system, J. Immunol. 155, 325-332
41. Baldwin, A.S. (1996) The NF-κB and IκB proteins: new discoveries and insights, Annu. Rev. Immunol. 14, 649-681
42. Kaltschmidt, C. et al. (1994) Transcription factor NF-κB is activated in microglia during experimental autoimmune encephalomyelitis, J. Neuroimmunol. 55, 99-106
43. Neurath, M.F., Pettersson, S., Büschenfelde, K.H. and Strober, W. (1996) Local administration of antisense phosphorothioate oligonucleotides to the p65 sub-unit of NF-κB abrogates established experimental colitis in mice, Nat. Med. 2, 998-1004
44. Liao, F., Ali, J., Green, T. and Muller, W.A. (1997) Soluble domain 1 of platelet-endothelial cell adhesion molecule (PECAM) is sufficient to block transendothelial migration in vitro and in vivo, J. Exp. Med. 185, 1349-1357
45. 4 integrin interaction, Proc. Natl. Acad. Sci. U. S. A. 92, 5714-5718
46. Zopf, D. and Roth, S. (1996) Oligosaccharide anti-infective agents, Lancet 347, 1017-1021
47. Rosen, S.D. and Bertozzi, C.R. (1994) The selectins and their ligands, Curr. Opin. Cell Biol 6, 663-673
48. O'Connell, D. et al. (1996) Calcium-dependent oligonucleotide antagonists specific for L-selectin, Proc. Natl. Acad. Sci. U. S. A. 93, 5883-5887
49. Wojcik, W.J., Swoveland, P., Zhang, X. and Vanguri, P. (1996) Chronic intrathecal infusion of phosphorothioate or phosphodiester antisense oligonucleotides against cytokine responsive gene-2/IP-10 in experimental allergic encephalomyelitis of Lewis rat, J. Pharmacol. Exp. Ther. 278, 404-410
50. Agrawal, S. (1996) Antisense oligonucleotides: towards clinical trials, Trends Biotechnol. 14, 376-387
51. Ridet, J.L. and Privat, A. (1995) Gene therapy in the central nervous system: direct versus indirect gene delivery, J. Neurosci. Res. 42, 289-293
52. Moritani, M. et al. (1996) Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes, J. Clin. Invest. 98, 1851-1859
53. Ludowyk, P.A., Willenborg, D.O. and Parish, C.R. (1992) Selective localization of neuro-specific T lymphocytes in the central nervous system, J. Neuroimmunol. 37, 237-250
54. Riddell, S.R. and Greenberg, P.D. (1995) Principles for adoptive T cell therapy of human viral diseases, Annu. Rev. Immunol. 13, 545-586